Riverfront Ventures

Riverfront Ventures is an early-stage venture capital fund based in Pittsburgh, Pennsylvania, founded in 2013 as the venture capital arm of Innovation Works, one of the most active seed-stage investors in the United States and the operator of the AlphaLab, AlphaLab Gear, AlphaLab Health and Robotics Factory accelerators. With approximately $25 million in assets under management, Riverfront invests in early-growth stage technology companies based in or close to the Pennsylvania region, focusing on software, healthcare and life sciences, and robotics sectors with large market potential. Initial investments typically range from $250,000 to $1 million, with further capital reserved for follow-on and average total investment per company of $1M to $1.5M. Riverfront co-invests with top-tier venture firms rather than leading rounds, helping Pittsburgh-area startups connect with the broader US capital ecosystem. Across roughly 23 disclosed investments and 5 portfolio exits, notable holdings include Aspinity, Swan, ValiCyber and Rimsys. The most significant exit was ALung Technologies, a medical device company acquired by LivaNova in May 2022, and the most recent investment was Handl Health -- an AI-based health benefits platform -- which received a Seed VC-II round from Riverfront in April 2024 and subsequently raised a $14 million Series A in February 2026. Riverfront Ventures' close integration with Innovation Works' accelerator platform gives the fund privileged access to Pittsburgh's top early-stage talent, particularly in robotics, healthcare and software. By co-investing alongside established venture firms from the coasts, Riverfront bridges regional deal flow with national capital networks, helping local founders scale beyond the Pittsburgh market.